title: In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.
authors.forename: Susan
authors.initials: S
authors.lastname: Brogly
authors.forename: Paige
authors.initials: P
authors.lastname: Williams
authors.forename: George R
authors.initials: GR
authors.lastname: Seage
authors.forename: Russell
authors.initials: R
authors.lastname: Van Dyke
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy*; D000293:Adolescent; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications; D011297:Prenatal Exposure Delayed Effects; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D013223:Statistics as Topic
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors